These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9158511)

  • 1. Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study.
    Ali-el-Dein B; Nabeeh A; el-Baz M; Shamaa S; Ashamallah A
    Br J Urol; 1997 May; 79(5):731-5. PubMed ID: 9158511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and large-dose intravesical instillation of epirubicin to prevent superficial bladder carcinoma recurrence after transurethral resection.
    Mitsumori K; Tsuchiya N; Habuchi T; Li Z; Akao T; Ohyama C; Sato K; Kato T
    BJU Int; 2004 Aug; 94(3):317-21. PubMed ID: 15291859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
    Ali-el-Dein B; el-Baz M; Aly AN; Shamaa S; Ashamallah A
    J Urol; 1997 Jul; 158(1):68-73; discussion 73-4. PubMed ID: 9186325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder.
    Koga H; Kuroiwa K; Yamaguchi A; Osada Y; Tsuneyoshi M; Naito S
    J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical 4'-epi-doxorubicin (epirubicin) versus bacillus Calmette-Guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer.
    Melekos MD; Chionis HS; Paranychianakis GS; Dauaher HH
    Cancer; 1993 Sep; 72(5):1749-55. PubMed ID: 8348504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled study of intravesical epirubicin with or without alpha 2b-interferon as prophylaxis for recurrent superficial transitional cell carcinoma of the bladder. Finnish Multicentre Study Group.
    Raitanen MP; Lukkarinen O
    Br J Urol; 1995 Dec; 76(6):697-701. PubMed ID: 8535711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two instillations of epirubicin as prophylaxis for recurrence after transurethral resection of Ta and T1 transitional cell bladder cancer: a prospective, randomized controlled study.
    Saika T; Tsushima T; Nasu Y; Miyaji Y; Saegusa M; Takeda K; Kumon H
    World J Urol; 2010 Aug; 28(4):413-8. PubMed ID: 20054553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional cell bladder tumours.
    Rosen M
    Br J Urol; 1997 Dec; 80(6):966. PubMed ID: 9439427
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravesical instillation of epirubicin: effect on tumour recurrence in patients with dysplastic epithelium after transurethral resection of superficial bladder tumour.
    Igawa M; Urakami S; Shirakawa H; Shiina H; Ishibe T; Kadena H; Usui T; Kawanishi M
    Br J Urol; 1996 Mar; 77(3):358-62. PubMed ID: 8814838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transurethral resection with perioperative instilation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective randomized multicenter study--Finnbladder III.
    Rajala P; Liukkonen T; Raitanen M; Rintala E; Kaasinen E; Helle M; Lukkarinen O
    J Urol; 1999 Apr; 161(4):1133-5; discussion 1135-6. PubMed ID: 10081854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical instillations of 4-epi-doxorubicin (epirubicin) in the prophylactic treatment of superficial bladder cancer: results of a controlled prospective study.
    Melekos MD; Dauaher H; Fokaefs E; Barbalias G
    J Urol; 1992 Feb; 147(2):371-5. PubMed ID: 1732596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravesical instillation with epirubicin as a prophylactic treatment for superficial bladder cancer--using two different schedules].
    Segawa N; Nishida T; Takahara K; Nomi H; Azuma H; Katsuoka Y
    Hinyokika Kiyo; 2008 Nov; 54(11):711-6. PubMed ID: 19068724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer.
    Hendricksen K; Witjes WP; Idema JG; Kums JJ; van Vierssen Trip OB; de Bruin MJ; Vergunst H; Caris CT; Janzing-Pastors MH; Witjes JA
    Eur Urol; 2008 May; 53(5):984-91. PubMed ID: 18248876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of immediate postoperative intravesical epirubicin instillation as an adjunct to standard adjuvant treatment in intermediate and high-risk non-muscle-invasive bladder cancer: A preliminary results of randomized controlled trial.
    Elsawy AA; El-Assmy AM; Bazeed MA; Ali-El-Dein B
    Urol Oncol; 2019 Mar; 37(3):179.e9-179.e18. PubMed ID: 30448030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravesical instillation of epirubicin in the prophylactic treatment of recurrent superficial bladder cancer].
    Kobayashi M; Sugaya Y; Yuzawa M; Morita T; Kobayashi Y; Tokue A
    Hinyokika Kiyo; 1998 Dec; 44(12):861-4. PubMed ID: 10028430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical epirubicin in the prophylaxis of superficial bladder cancer.
    Sengör F; Beysel M; Erdoğan K; Erol A; Tuzluoğlu D
    Int Urol Nephrol; 1996; 28(2):201-6. PubMed ID: 8836789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study--FinnBladder III long-term results.
    Rajala P; Kaasinen E; Raitanen M; Liukkonen T; Rintala E;
    J Urol; 2002 Sep; 168(3):981-5. PubMed ID: 12187204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing intra-arterial chemotherapy combined with intravesical chemotherapy versus intravesical chemotherapy alone: a randomised prospective pilot study for T1G3 bladder transitional cell carcinoma after bladder-preserving surgery.
    Chen J; Yao Z; Qiu S; Chen L; Wang Y; Yang J; Li J
    Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1521-1526. PubMed ID: 23511989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Continuous intravesical instillation of epirubicin immediately after transurethral resection of superficial bladder cancer: a prospective controlled study].
    Maekawa S; Suzuki H; Ohkubo K; Aoki Y; Okada T; Maeda H; Ogura K; Arai Y
    Hinyokika Kiyo; 2000 May; 46(5):301-6. PubMed ID: 10876750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of intravesical chemoimmunotherapy with epirubicin and bacillus Calmette-Guérin for prophylaxis of recurrence of superficial bladder cancer: a preliminary report.
    Uekado Y; Hirano A; Shinka T; Ohkawa T
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S65-8. PubMed ID: 7994790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.